Language selection

Government of Canada / Gouvernement du Canada

Search

Blood-brain barrier transport of amyloid beta peptides in efflux pump knock-out animals evaluated by in vivo optical imaging

From National Research Council Canada

DOIResolve DOI: https://doi.org/10.1186/2045-8118-10-13
AuthorSearch for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1
Affiliation
  1. National Research Council of Canada. Human Health Therapeutics
FormatText, Article
SubjectAlzheimer’s disease; Aβ peptides; Blood-brain barrier; Mdr-1a/b P-glycoprotein; Abcb1a/b; Abcg2; Optical imaging
Abstract
Aβ transport (flux) across the blood-brain barrier (BBB) is thought to contribute to the pathogenesis of Alzheimer’s disease as well as to elimination of toxic amyloid from the brain by immunotherapy. Several BBB transporters have been implicated in Aβ exchange between brain parenchyma and the circulation, including efflux transporters P-glycoprotein/ABCB1 and BCRP/ABCG2. Here we describe an application of in vivo optical imaging methods to study Aβ transport across the BBB in wild-type or animals deficient in specific efflux transporters.
Publication date
In
  • Fluids and barriers of the CNS 10, no. 13 (25 February 2013).
LanguageEnglish
Peer reviewedYes
NPARC number21275157
Export citationExport as RIS
Report a correctionReport a correction (opens in a new tab)
Record identifierdd0cc51f-e0c0-4229-a391-d9e21230380f
Record created2015-05-21
Record modified2020-04-22
Date modified: